Clinical Trial

Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis

Recruiting
View on ClinicalTrials.gov →
Summary
Mastocytosis is very rare and highly heterogeneous group of disorders, characterized by the accumulation of clonal mast cells which can infiltrate several organs and tissues. Bones are the most frequent localization of systemic mastocytosis. The aim of our research was to explain the potential role of sclerostin in the pathogenesis of bone disease in mastocytosis.
Trial Details
NCT Number NCT06440148
Lead Sponsor Medical University of Lublin
Conditions Mastocytosis, Bones
Enrollment 50 participants
Start Date 2019-09-01
Primary Completion 2024-05-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-06-03